Absci Balance Sheet Health
Financial Health criteria checks 5/6
Absci has a total shareholder equity of $210.3M and total debt of $1.4M, which brings its debt-to-equity ratio to 0.7%. Its total assets and total liabilities are $245.0M and $34.7M respectively.
Key information
0.65%
Debt to equity ratio
US$1.37m
Debt
| Interest coverage ratio | n/a |
| Cash | US$152.48m |
| Equity | US$210.34m |
| Total liabilities | US$34.65m |
| Total assets | US$244.99m |
Recent financial health updates
Does Absci (NASDAQ:ABSI) Have A Healthy Balance Sheet?
Jul 19
Is Absci (NASDAQ:ABSI) A Risky Investment?
Nov 13Is Absci (NASDAQ:ABSI) A Risky Investment?
Jun 17Recent updates
Absci Corporation: Drawing Potential Insights On ABS-101 And ABS-201
Jan 29Does Absci (NASDAQ:ABSI) Have A Healthy Balance Sheet?
Jul 19Absci Looks Cheap And Positioned For Growth With AMD's AI Backing
Jan 13Absci Corporation: Struggling To Live Up To Its AI Promise
Nov 20Is Absci (NASDAQ:ABSI) A Risky Investment?
Nov 13Absci: Embryonic Pipeline Looks Expensive Relative To Peers
Oct 29Absci: AI-Driven Platform Could Establish Best-In-Class TL1A Drug Targeting Profile
Oct 03Absci Corporation Leverages AI For Rapid Drug Discovery And Promising Partnerships
Jul 28Is Absci (NASDAQ:ABSI) A Risky Investment?
Jun 17Absci: 'AI' Tag Keeping Company Afloat While Searching For Right Formula
May 16Absci: Differentiated Antibody Discovery Play
Feb 27Absci GAAP EPS of -$0.32 misses by $0.01, revenue of $1M misses by $0.68M
Aug 11Financial Position Analysis
Short Term Liabilities: ABSI's short term assets ($175.0M) exceed its short term liabilities ($29.7M).
Long Term Liabilities: ABSI's short term assets ($175.0M) exceed its long term liabilities ($4.9M).
Debt to Equity History and Analysis
Debt Level: ABSI has more cash than its total debt.
Reducing Debt: ABSI's debt to equity ratio has reduced from 9.4% to 0.7% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: ABSI has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: ABSI has less than a year of cash runway if free cash flow continues to reduce at historical rates of 9.6% each year
Discover healthy companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2026/03/12 06:54 |
| End of Day Share Price | 2026/03/12 00:00 |
| Earnings | 2025/09/30 |
| Annual Earnings | 2024/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Absci Corporation is covered by 14 analysts. 9 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Michael Ryskin | BofA Global Research |
| Vamil Divan | Guggenheim Securities, LLC |
| null null | Guggenheim Securities, LLC |